Sandoz Asserts ‘Biosimilars Leadership’ As It Completes Just-Evotec Acquisition

Expands In-House Development And Manufacturing Capabilities

 
• By Dave Wallace
  
Sandoz says it is taking the lead in biosimilars (Shutterstock)

More from Deals

More from Business